WATERTOWN, Mass., April 16, 2024 (GLOBE NEWSWIRE) -- Eloxx Pharmaceuticals, Inc. (OTC: ELOX), a leader in ribosomal RNA-targeted genetic therapies for rare diseases, today provided program updates for ...

ELX Futures, a US-based electronic futures exchange, plans to compete with the NYSE Liffe and Eurex derivatives markets by launching interest rate products using the maker-taker and taker-maker ...

ELX-02 treatment improved podocyte foot process effacement in all three patients by an average of 60% based on a blinded kidney biopsy analysis by NIPOKA GmbH Biopsy results support clinical benefit ...

Results of our renal impairment study for ELX-02 support the expansion of our research in the kidney beyond nephropathic cystinosis into other areas such as autosomal dominant polycystic kidney ...

A new futures exchange formed by 12 financial institutions announced on Tuesday that its name will be ELX Electronic Liquidity Exchange. A new futures exchange formed by 12 financial institutions ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Electronic Liquidity Exchange (ELX), a new US futures exchange backed by a group of banks, dealers and ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. ELX, the upstart Treasury futures exchange struggling to gain traction against its dominant rival, CME Group, ...

WatchGuard Video has announced the release of Evidence Library Express (ELX), an all new video management software program designed to enable an agency to deploy the WatchGuard 4RE HD In-Car Video ...

WATERTOWN, Mass., Sept. 07, 2023 (GLOBE NEWSWIRE) -- Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX), a leader in ribosomal RNA-targeted genetic therapies for rare diseases, today provided an update on the ...

ELX-02 Granted Orphan Drug Designation (ODD) from U.S. Food and Drug Administration (FDA) for Treatment of Alport Syndrome Pre-Investigational New Drug (IND) Meeting Requested with U.S. FDA for ELX-02 ...